Novartis AG is 227.9x more valuable than Damora Therapeutics, Inc. by market capitalization ($282.64 B vs $1.24 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DMRA | NVS |
|---|---|---|
| Market cap | $1.24 B | $282.64 B |
| US-listed rank | #2475 | #47 |
| Net income (latest FY) | -$209.84M | - |
| SEC filings | 329 | 947 |
Novartis AG is 227.9x more valuable than Damora Therapeutics, Inc. by market capitalization ($282.64 B vs $1.24 B).
Full pages: Damora Therapeutics, Inc. and Novartis AG, or browse the full rankings.